SCHEMBL20825932

SCHEMBL20825932

Cc1ccc2c(c1)c1cc(C(C)(C)C)ccc1n2-c1ccc2cc(-c3ccc4cc(-n5c6ccc(C(C)(C)C)cc6c6cc(C(C)(C)C)ccc65)ccc4c3)ccc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGES O14684 2/20 0.38
▸ KCNH2 Q12809 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ MAPT P10636 1/20 0.35
▸ TSHR P16473 1/20 0.34
▸ CCR9 P51686 1/20 0.33
▸ HTR1D P28221 1/20 0.33
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2A6 P11509 1/20 0.32
▸ SERPINE1 P05121 1/20 0.32
▸ PTAFR P25105 1/20 0.32
▸ NR3C1 P04150 1/20 0.32
▸ KIF11 P52732 1/20 0.31
▸ LCK P06239 1/20 0.31
▸ KIT P10721 1/20 0.31
▸ SRC P12931 1/20 0.31
▸ KDR P35968 1/20 0.31
▸ CASR P41180 1/20 0.31
▸ NR1H4 Q96RI1 1/20 0.31
▸ OPRM1 P35372 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20826233 0.93 PTGES (0.42) PTGESKCNH2ALDH1A1MAPTHTR1D
SCHEMBL20825696 0.93 PTGES (0.42) PTGESKCNH2ALDH1A1MAPTHTR1D
SCHEMBL20826223 0.88 KCNH2 (0.39) PTGESKCNH2ALDH1A1MAPTHTR1D
SCHEMBL20826117 0.88 KCNH2 (0.39) PTGESKCNH2ALDH1A1MAPTHTR1D
SCHEMBL20826232 0.88 PTGES (0.35) PTGESKCNH2ALDH1A1MAPTTSHR
SCHEMBL29293968 0.87 TSHR (0.39) PTGESKCNH2ALDH1A1MAPTTSHR
SCHEMBL20938415 0.85 PTGES (0.38) PTGESKCNH2ALDH1A1MAPTHTR1D
SCHEMBL20825698 0.84 PTGES (0.44) PTGESKCNH2SERPINE1KIF11CASR
SCHEMBL2719134 0.84 TSHR (0.44) KCNH2ALDH1A1MAPTTSHRHTR1D
SCHEMBL26381945 0.84 TSHR (0.44) KCNH2ALDH1A1MAPTTSHRHTR1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10868260-B2 Organic compound and photoelectric conversion element CANON KABUSHIKI KAISHA (JP) 2020-12-15 — — US disclosed
US-20190088885-A1 ORGANIC COMPOUND AND PHOTOELECTRIC CONVERSION ELEMENT CANON KABUSHIKI KAISHA (JP) 2019-03-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10868260-B2 Organic compound and photoelectric conversion element CRY1, CYP1A1, CCNE2 PTGES 3027/4885KCNH2 83/4885ALDH1A1 476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback